Anagliptin (hydrochloride)


CAS No. : 1359670-56-6

(Synonyms: SK-0403 (hydrochloride))

1359670-56-6
Price and Availability of CAS No. : 1359670-56-6
Size Price Stock
100 mg Get quote
250 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-14877A
M.Wt: 419.91
Formula: C19H26ClN7O2
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 1359670-56-6 :

Anagliptin (SK-0403) hydrochloride is a highly selective, potent, orally active inhibitor of dipeptidyl peptidase 4 (DPP-4), with an IC50 of 3.8 nM, and less selective at DPP-8 and DDP-9 with IC50s of 68 nM and 60 nM, respectively[1]. IC50 & Target:IC50: 3.8 nM (DPP-4), 68 nM (DPP-8), 60 nM (DPP-9)[1] In Vitro:Anagliptin (SK-0403) (0-100 μM; 24 h) attenuates s-DPP-4-induced smooth muscle cells proliferation[2].
Anagliptin (100 μM; 10 min) reduces TNF-α production in cultured monocytes[2].
Anagliptin (0.001-10 μM; 24 h) significantly suppresses sterol regulatory element‐binding protein activity in HepG2 cells (21% decrease)[3]. In Vivo:Anagliptin (SK-0403) (0.3%; in diet; 16 weeks) reduces atherosclerotic lesion and does not increase the number of circulating EPCs in apoliporotein E (apoE)-deficient mice[2].
Anagliptin (0.3%; in diet; 4 weeks) exhibits a lipid‐lowering effect in a hyperlipidemic mice model[3].

Your information is safe with us.